{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:49:22Z","timestamp":1786996162429,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.radonc.2024.110619","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T06:54:18Z","timestamp":1731394458000},"page":"110619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-2762","authenticated-orcid":false,"given":"J.","family":"Varlotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-265X","authenticated-orcid":false,"given":"R.","family":"Voland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"DeCamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shweihat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nwanwene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tirona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Pacioles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6243-702X","authenticated-orcid":false,"given":"J.","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Silbermins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Flickinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110619_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0010","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neo.2017.07.007","article-title":"What\u2019s new in SCLC?","volume":"19","author":"Oronsky","year":"2017","journal-title":"A review Neoplasia"},{"key":"10.1016\/j.radonc.2024.110619_b0015","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line Atezolizumab plus chemotherapy in extensive-stage small cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110619_b0020","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small-cell lung cancer(CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110619_b0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2024.110619_b0030","doi-asserted-by":"crossref","unstructured":"Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol 1999; J Clin Oncol 17: 2092-2099.","DOI":"10.1200\/JCO.1999.17.7.2092"},{"key":"10.1016\/j.radonc.2024.110619_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomized controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110619_b0040","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jtho.2017.06.015","article-title":"Randomized phase II study comparing prophylactic cranial irradiation and consolidative extracranial irradiation for extensive-disease small cell lung cancer(ED-SCLC): NRG Oncology 0937","volume":"12","author":"Gore","year":"2017","journal-title":"J Thorac"},{"key":"10.1016\/j.radonc.2024.110619_b0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110619_b0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: A multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0055","unstructured":"https:\/\/ncdbapp.facs.org\/puf\/."},{"key":"10.1016\/j.radonc.2024.110619_b0060","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbe-Hurder","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0065","series-title":"Toolkit for Weighting and Analysis of Nonequivalent Groups (TWANG) Website [Internet]","author":"Griffin","year":"2014"},{"key":"10.1016\/j.radonc.2024.110619_b0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG Oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cllc.2019.06.014","article-title":"Survival outcomes with thoracic radiotherapy in extensive-stage small cell lung cancer: a propensity score-matched analysis of the National Cancer Database","volume":"20","author":"Tian","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110619_b0080","doi-asserted-by":"crossref","unstructured":"Peng J, Zhang L, Wang L, et al. PD-L1 inhibitors combined with thoracic radiotherapy in first-line treatment of extensive stage small cell lung cancer: a propensity score-matched, real world study. Int J Radiat Oncol Biol Phys, Vol. 117Issue 2SupplementS127\u2013S128, Published in issue: October 01, 2023.","DOI":"10.1016\/j.ijrobp.2023.06.472"},{"key":"10.1016\/j.radonc.2024.110619_b0085","doi-asserted-by":"crossref","unstructured":"Yao Y, Li B, Song R, et al. Thoracic radiotherapy improves the outcomes of extensive stage small cell lung cancer patients receiving first-line immunotherapy: a multicenter retrospective analysis. Int J Radiat Oncol Biol Phys, Vol. 117Issue 2SupplementS57Published in issue: October 01, 2023.","DOI":"10.1016\/j.ijrobp.2023.06.351"},{"key":"10.1016\/j.radonc.2024.110619_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30742-7","article-title":"High-dose versus standard-dose twide daily thoracic radiotherapy for patientsd with limited stage-small lung cancer: an open-label, randomised phase 2 trial","volume":"22","author":"Gronberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomized superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0100","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1200\/JCO.22.01359","article-title":"High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer:CALGB 30610 (Alliance)\/RTOG 0538","volume":"41","author":"Bogart","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110619_b0105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.2022.16464","article-title":"Effect of first-line serplulimab vs. placebo added to chemotherapy on survival in patients with extensive stage small cell lung cancer: the Astrum-005 randomized clinical trial","volume":"328","author":"Cheng","year":"2022","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2024.110619_b0110","doi-asserted-by":"crossref","unstructured":"Gay CM, Stewart CA, Park EM, et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39: 346-360. E7, 2021.","DOI":"10.1016\/j.ccell.2020.12.014"},{"key":"10.1016\/j.radonc.2024.110619_b0115","doi-asserted-by":"crossref","unstructured":"Xie M, Chugh P, Broadhurst H, et al. Durvalumab + platinum-etoposide in first-line extensive-stage small cell lung cancer(ES-SCLC):Exploratory analysis of SCLC molecular subtypes in Caspian, AACR annual meeting. New Orleans, LA, 2022 (abstract CT024).","DOI":"10.1158\/1538-7445.AM2022-CT024"},{"key":"10.1016\/j.radonc.2024.110619_b0120","article-title":"Prognostic implications of small cell lung cancer transcritional subtyping for CNS metastases","volume":"8","author":"Tringale","year":"2024","journal-title":"JCO Precis OncoI"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:30:24Z","timestamp":1734568224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024042816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S0167814024042816"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110619","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110619"}}